- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Baxter International Inc
Add to PortfolioBAX:US
51.9900 USD 0.2600 0.50%As of 20:04:05 ET on 05/25/2012.
Snapshot for Baxter International Inc (BAX)
| Open: | 52.2400 | Day's Range: | 51.8900 - 52.6100 | Volume: | 1,863,852 | Bid: | 52.0000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 52.2500 | 52wk Range: | 47.5518 - 62.5000 | 1-Yr Rtn: | -9.97% | Ask: | 52.0100 |
Key Statistics for BAX
| Current P/E Ratio (ttm) | 12.2042 |
|---|---|
| Estimated P/E (12/2012) | 11.4642 |
| Earnings Per Share (USD) (ttm) | 4.2600 |
| Est. EPS (USD) (12/2012) | 4.5350 |
| Est. PEG Ratio | 1.3027 |
| Market Cap (M USD) | 28,625.45 |
| Shares Outstanding (M) | 550.60 |
| Enterprise Value (M USD) (ttm) | 31,801.45 |
| Enterprise Value/EBITDA (ttm) | 8.88 |
| Price/Book (mrq) | 4.2853 |
| Price/Sale (ttm) | 2.0959 |
| Dividend Indicated Gross Yield | 2.5769 |
| Next Earnings Announcement | 07/20/2012 |
More BAX Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BAX
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for BAX
Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company's products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and research laboratories.
| Robert L Parkinson JrChairman/CEO | Robert J Hombach "Bob"VP/Chief Financial Officer |
| Robert M Davis "Rob"VP/Pres:Medical Products | Ludwig N HantsonVP/Pres:Bioscience |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page